[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France]. [electronic resource]
- Annales de pathologie Oct 2014
- 352-65 p. digital
Publication Type: English Abstract; Journal Article; Practice Guideline
0242-6498
10.1016/j.annpat.2014.08.018 doi
Biomarkers, Tumor--analysis Breast Neoplasms--chemistry False Negative Reactions Female France Humans Immunohistochemistry--methods In Situ Hybridization In Situ Hybridization, Fluorescence Neoplasm Metastasis--pathology Neoplasm Recurrence, Local Prognosis Receptor, ErbB-2--analysis